Robust Pipeline To Pump Out Future Growth Regeneron's top blockbuster drug, Dupixent, was recently approved by the FDA for COPD treatment. However, this approval occurred when REGN was in a downward ...

Once trial phases are completed, the FDA reviews the results and decides whether the investigational ... team can help you determine if it’s a good option for you. In a recent Regeneron survey, ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...